investingreview.org logo
Obtenez les faits, trouvez le meilleur et évitez la fraude
Nothings Found.

Rebalancing Your Portfolio: Cullen Capital Management's Q3 2022 vs Q4 2022 Holdings

Ava Hoppe | 25 April, 2023

As an investor, it's crucial to keep an eye on your portfolio and make changes when necessary. One important aspect of this is monitoring your holdings to ensure that they align with your goals and risk tolerance. This is where quarterly filings such as Cullen Capital Management's Q3 2022 vs Q4 2022 13F Holdings Comparison come into play. In this blog post, we'll take a look at the changes in holdings of this fund and what it could mean for your portfolio.

Introduction:

Cullen Capital Management, LLC is an investment management firm that focuses on international value equity investing. Each quarter, the company files a 13F with the SEC, which details its holdings at the end of the quarter. The Q3 2022 vs Q4 2022 comparison offers a snapshot of the changes in the company's holdings over the period. It's important to note that this information is not a recommendation to buy, sell or hold a particular security. It's merely a tool to help investors stay informed about the company's portfolio.

Main Body:

The Cullen Capital Management Q3 2022 vs Q4 2022 13F Holdings Comparison report shows several notable changes in the company's holdings. The largest decrease in shares was seen in Novartis AG (ADR) (NVS), with a 4.1% drop from 3,467,273 shares in Q3 to 2,784,843 shares in Q4. This decline was mirrored by a decrease in value from $263,547,000 to $252,640,000. Merck & Co. Inc. (MRK) and Johnson & Johnson (JNJ) also posted significant decreases by 6.1% and 17.7%, respectively.

On the other hand, several holdings saw an increase in shares between Q3 and Q4. Siemens AG (ADR) (SIEGY) had the largest gain, with holdings rising by 20.9% from 3,645,876 shares in Q3 to 3,136,570 shares in Q4. This change also represented a value increase from $178,466,000 to $215,764,000. Other companies that experienced an increase in shares included Nippon Telegraph & Telephone Corporation (NTTYY) and Nestle SA (ADR) (NSRGY) that posted 3.7% and 6.1% growth respectively.

Looking at industry trends, the 13F report reveals a shift in holdings from healthcare to financials, manufacturing, and energy. Energy holdings saw the most impressive gains, with United Overseas Bank Ltd (UOVEY), TotalEnergies SE (ADR) (TOT), and Vale SA (ADR) (VALE) all posting double-digit percentage gains.

Investors must keep in mind that a 13F filing only provides a snapshot of the company's holdings at the end of the quarter. Therefore, it's essential to consider the company's broader investment strategy and the reasons for any changes in the portfolio.

Conclusion:

In conclusion, the Cullen Capital Management Q3 2022 vs Q4 2022 13F Holdings Comparison report provides valuable insights for investors. It highlights the significant changes in the company's holdings over the two quarters, including the increase or decrease in shares and value. The report can be a useful tool for investors to consider how the company's holdings align with their investment goals and risk tolerance. However, it's important to remember that the filing only provides a snapshot and should not be considered a recommendation to buy, sell, or hold any security.

De nombreuses personnes ont été brûlées par des fraudes et des stratagèmes de Ponzi. Nous avons donc créé ce site Web pour vous aider, en tant qu’investisseur potentiel, à obtenir les faits, à trouver le meilleur des moyens, et à éviter la fraude et les stratagèmes de Ponzi.

Toutes les informations fournies sur ce site sont fournies sans garantie et à des fins d'information uniquement.
InvestingReview.org ne fournit pas de conseils en investissement. InvestingReview.org n'est pas un conseiller en investissement et n'est ni endossé ni affilié à un organisme de réglementation américain ou non américain.


Entreprises récemment recherchées

Remarque: les données de recherche sont accumulées par des tiers et actualisées une fois par jour.

Copyright © 2023 by InvestingReview.org / Tous droits réservés.